Aelis Farma SA
No trades
No trades
Compare with Aelis Farma SA
−0.330 EUR
−6.43 M EUR
0.00 EUR
4.16 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Pier Vincenzo Piazza
Website
Headquarters
Bordeaux
Founded
2013
IPO date
Feb 18, 2022
ISIN
FR0014007ZB4
FIGI
BBG01522XLZ9
Identifiers
ISIN FR0014007ZB4
Aelis Farma SA is a biopharmaceutical company. It engages in the business of researching and developing pharmaceutical products. The company was founded by Valérie Scappaticci and Pier Vincenzo Piazza on October 7, 2013 and is headquartered in Bordeaux, France.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of AELIS is 0.799 EUR — it has increased by 1.25% in the past 24 hours. Watch Aelis Farma SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Aelis Farma SA stocks are traded under the ticker AELIS.
AELIS stock has fallen by −7.95% compared to the previous week, the month change is a −20.12% fall, over the last year Aelis Farma SA has showed a −34.51% decrease.
AELIS reached its all-time high on Feb 18, 2022 with the price of 14.480 EUR, and its all-time low was 0.672 EUR and was reached on Jul 23, 2025. View more price dynamics on AELIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AELIS stock is 2.53% volatile and has beta coefficient of 0.47. Track Aelis Farma SA stock price on the chart and check out the list of the most volatile stocks — is Aelis Farma SA there?
Today Aelis Farma SA has the market capitalization of 10.97 M, it has decreased by −8.89% over the last week.
Yes, you can track Aelis Farma SA financials in yearly and quarterly reports right on TradingView.
Aelis Farma SA is going to release the next earnings report on Apr 5, 2027. Keep track of upcoming events with our Earnings Calendar.
AELIS net income for the last half-year is −2.41 M EUR, while the previous report showed −2.11 M EUR of net income which accounts for 0.00% change. Track more Aelis Farma SA financial stats to get the full picture.
No, AELIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 9, 2026, the company has 24 employees. See our rating of the largest employees — is Aelis Farma SA on this list?
Like other stocks, AELIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aelis Farma SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aelis Farma SA technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aelis Farma SA stock shows the sell signal. See more of Aelis Farma SA technicals for a more comprehensive analysis.